Previous 10 | Next 10 |
Owens & Minor has been ¨saved¨ by the pandemic. The company has seen solid momentum in 2021, giving management enough confidence to pursue a rather large deal again at the start of 2022. This feels a bit early given the history and higher leverage situation, as I hav...
NEW YORK, NY / ACCESSWIRE / February 17, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Apria, Inc. (NASDAQ:APR)'s sal...
NEW YORK, NY / ACCESSWIRE / January 25, 2022 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: GCP Applied Technologies Inc. (NYSE:GCP) concerning potential violations of the federal securities laws and/or breaches of fiduciary...
Apria Inc ( NASDAQ: APR ) spiked 25% after it announced that it had entered a definitive agreement with Owens & Minor ( NYSE: OMI ) whereby Owens would acquire its common stock shares for $37.50 per share representing a total equity value of roughly $1.45 billion. ...
MONSEY, N.Y., Jan. 10, 2022 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Apria, Inc. (Nasdaq: APR) (“Apria”) acted in the best interests of APR shareholders in approving the proposed acquisition of Apria by Owens & M...
Shares of home healthcare equipment provider Apria (NASDAQ: APR) were skyrocketing 26.2% higher as of 12:05 p.m. ET on Monday. The huge jump came after Owens & Minor (NYSE: OMI) announced plans to acquire Apria for around $1.45 billion. Owens & Minor offered $37....
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, trader! We’re starting off the week with a breakdown of the biggest pre-market stock movers for Monday! Source: Shutterstock Moving stocks this morning are clinical trial results, collaboration ...
Citi has resumed coverage of home healthcare equipment provider Apria (APR +1.9%) with a buy rating and $39 price target (~32% upside). Analyst Ralph Giacobbe writes that the company stands to benefit from increased demand for oxygen due to Long COVID, and an increase in demand for sleep apne...
Apria (NASDAQ:APR) prices its secondary offering of 4.5M shares by a selling stockholder at $31.50 per share. The offering is expected to close on November 15, 2021, subject to customary closing conditions. Shares of APR down over 1.5% premarket. Previously (Nov. 9): Apria launches ...
Palm Beach, FL – November 9, 2021 – FinancialNewsMedia.com News Commentary – Over the last few years, and with the ‘help’ of the pandemic, home health care medical equipment industry has surged. Home medical equipment are medical devices that o...
News, Short Squeeze, Breakout and More Instantly...
Apria Inc. Company Name:
APR Stock Symbol:
NASDAQ Market:
Image source: The Motley Fool. Apria Healthcare Group Inc. (NASDAQ: APR) Q1 2022 Earnings Call May 03, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Apria Healthcare Group Inc. (APR) Q1 2022 Earnings Call Transcri...
INDIANAPOLIS, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR), a leading provider of integrated home healthcare equipment and related services in the United States, announced today financial results for the fourth quarter an...
INDIANAPOLIS, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR), a leading provider of home medical equipment, supplies and related services in the United States, announced today that the waiting period has expired under the H...